David Kent, MD
Otolaryngology · Nashville, TNNPI 1851612568
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 28 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Inspire Medical Systems, Inc. accounts for 88.2% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2019 at $1,077 and has fallen 59.2% since, to $440 in 2025.
Across 28 payments — averaging $141.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$4K
- Jazz Pharmaceuticals Inc.$220
- Smith+Nephew$213
- Regeneron Healthcare Solutions, Inc.$34
Across 58 payments — averaging $3293.75 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Inspire Medical Systems, Inc.$191K
What the payments were for
- Travel & lodging$150%
- Food & beverage$3,955100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 22 | $3,502 |
| Jazz Pharmaceuticals Inc. | 3 | $220 |
| Smith+Nephew | 2 | $213 |
| Regeneron Healthcare Solutions, Inc. | 1 | $34 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,970 in reported general payments places this provider in the 80th percentile of 191 otolaryngology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelastine Hcl | 12 | $329 |
| Gabapentin | 16 | $240 |
| Pregabalin | 20 | $119 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Nashville
- Rakesh ChandraNashville$381K
- Michael TopfNashville$36K
- Naweed ChowdhuryNashville$14K
- Steven EnrichNashville$11K
- Kareem TawfikNashville$10K
- Mark WilliamsNashville$8K
- Matthew SpeyerNashville$6K
- Kyle MannionNashville$4K
- Charles BabbNashville$3K
- Brian CameronNashville$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.